Neoadjuvant chemotherapy and bevacizumab for colorectal peritoneal metastases: clinical and translational outcomes of the phase II BEV-IP trial.

Chia DKA, Demuytere J, Hoorens A, De Meuleneir K, Cosyns S, Van der Speeten K, Liberale G, Vansteenkiste F, Willaert W, Ceelen W

Open source

DOI: 10.1016/j.tranon.2026.102957
Published: 2026 Oct
Container: Translational oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.tranon.2026.102957,
  title = {Neoadjuvant chemotherapy and bevacizumab for colorectal peritoneal metastases: clinical and translational outcomes of the phase II BEV-IP trial.},
  author = {Chia DKA and Demuytere J and Hoorens A and De Meuleneir K and Cosyns S and Van der Speeten K and Liberale G and Vansteenkiste F and Willaert W and Ceelen W},
  year = {2026},
  journal = {Translational oncology},
  doi = {10.1016/j.tranon.2026.102957},
  url = {https://doi.org/10.1016/j.tranon.2026.102957}
}

RIS

TY  - JOUR
TI  - Neoadjuvant chemotherapy and bevacizumab for colorectal peritoneal metastases: clinical and translational outcomes of the phase II BEV-IP trial.
AU  - Chia DKA
AU  - Demuytere J
AU  - Hoorens A
AU  - De Meuleneir K
AU  - Cosyns S
AU  - Van der Speeten K
AU  - Liberale G
AU  - Vansteenkiste F
AU  - Willaert W
AU  - Ceelen W
PY  - 2026
JO  - Translational oncology
DO  - 10.1016/j.tranon.2026.102957
UR  - https://doi.org/10.1016/j.tranon.2026.102957
ER  -

APA

DKA, C., J, D., A, H., K, D. M., S, C., K, V. D. S., G, L., F, V., W, W., & W, C. (2026). Neoadjuvant chemotherapy and bevacizumab for colorectal peritoneal metastases: clinical and translational outcomes of the phase II BEV-IP trial.. Translational oncology. https://doi.org/10.1016/j.tranon.2026.102957

Source records

pubmed · retrieved 2026-09-26T23:53:47.941Z